158 related articles for article (PubMed ID: 12151056)
1. Identification of inhibitors of the HIV-1 gp41 six-helix bundle formation from extracts of Chinese medicinal herbs Prunella vulgaris and Rhizoma cibotte.
Liu S; Jiang S; Wu Z; Lv L; Zhang J; Zhu Z; Wu S
Life Sci; 2002 Aug; 71(15):1779-91. PubMed ID: 12151056
[TBL] [Abstract][Full Text] [Related]
2. Tannin inhibits HIV-1 entry by targeting gp41.
Lü L; Liu SW; Jiang SB; Wu SG
Acta Pharmacol Sin; 2004 Feb; 25(2):213-8. PubMed ID: 14769212
[TBL] [Abstract][Full Text] [Related]
3. [Isolation and characterization of the anti-HIV active component from Eucommia ulmoides].
Lv L; Sun YR; Xu W; Liu SW; Rao JJ; Wu SG
Zhong Yao Cai; 2008 Jun; 31(6):847-50. PubMed ID: 18998566
[TBL] [Abstract][Full Text] [Related]
4. High throughput screening and characterization of HIV-1 entry inhibitors targeting gp41: theories and techniques.
Liu S; Jiang S
Curr Pharm Des; 2004; 10(15):1827-43. PubMed ID: 15180543
[TBL] [Abstract][Full Text] [Related]
5. N-substituted pyrrole derivatives as novel human immunodeficiency virus type 1 entry inhibitors that interfere with the gp41 six-helix bundle formation and block virus fusion.
Jiang S; Lu H; Liu S; Zhao Q; He Y; Debnath AK
Antimicrob Agents Chemother; 2004 Nov; 48(11):4349-59. PubMed ID: 15504864
[TBL] [Abstract][Full Text] [Related]
6. Rapid and automated fluorescence-linked immunosorbent assay for high-throughput screening of HIV-1 fusion inhibitors targeting gp41.
Liu S; Boyer-Chatenet L; Lu H; Jiang S
J Biomol Screen; 2003 Dec; 8(6):685-93. PubMed ID: 14711394
[TBL] [Abstract][Full Text] [Related]
7. A comparison of HIV-1 integrase inhibition by aqueous and methanol extracts of Chinese medicinal herbs.
Au TK; Lam TL; Ng TB; Fong WP; Wan DC
Life Sci; 2001 Feb; 68(14):1687-94. PubMed ID: 11263681
[TBL] [Abstract][Full Text] [Related]
8. Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41.
Liu S; Lu H; Zhao Q; He Y; Niu J; Debnath AK; Wu S; Jiang S
Biochim Biophys Acta; 2005 May; 1723(1-3):270-81. PubMed ID: 15823507
[TBL] [Abstract][Full Text] [Related]
9. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
Sun W; Wang HT; Xia CL; Wu SG; Jiang SB; Jiang ZH; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1127-31. PubMed ID: 18676243
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening method of inhibitors that block the interaction between 2 helical regions of HIV-1 gp41.
Jin BS; Lee WK; Ahn K; Lee MK; Yu YG
J Biomol Screen; 2005 Feb; 10(1):13-9. PubMed ID: 15695339
[TBL] [Abstract][Full Text] [Related]
11. Removal of polyphenolic compounds from aqueous plant extracts using polyamide minicolumns.
Collins RA; Ng TB; Fong WP; Wan CC; Yeung HW
Biochem Mol Biol Int; 1998 Jul; 45(4):791-6. PubMed ID: 9713703
[TBL] [Abstract][Full Text] [Related]
12. Differential activities of plant polyphenols on the binding and internalization of cholera toxin in vero cells.
Morinaga N; Iwamaru Y; Yahiro K; Tagashira M; Moss J; Noda M
J Biol Chem; 2005 Jun; 280(24):23303-9. PubMed ID: 15814610
[TBL] [Abstract][Full Text] [Related]
13. Anti-HIV-1 activity of herbs in Labiatae.
Yamasaki K; Nakano M; Kawahata T; Mori H; Otake T; Ueba N; Oishi I; Inami R; Yamane M; Nakamura M; Murata H; Nakanishi T
Biol Pharm Bull; 1998 Aug; 21(8):829-33. PubMed ID: 9743251
[TBL] [Abstract][Full Text] [Related]
14. Tannins and related polyphenols of euphorbiaceous plants. XI. Three new hydrolyzable tannins and a polyphenol glucoside from Euphorbia humifusa.
Yoshida T; Amakura Y; Liu YZ; Okuda T
Chem Pharm Bull (Tokyo); 1994 Sep; 42(9):1803-7. PubMed ID: 7954930
[TBL] [Abstract][Full Text] [Related]
15. Trilobatin as an HIV-1 entry inhibitor targeting the HIV-1 Gp41 envelope.
Yin S; Zhang X; Lai F; Liang T; Wen J; Lin W; Qiu J; Liu S; Li L
FEBS Lett; 2018 Jul; 592(13):2361-2377. PubMed ID: 29802645
[TBL] [Abstract][Full Text] [Related]
16. A novel enzyme-linked immunosorbent assay for screening HIV-1 fusion inhibitors targeting HIV-1 Gp41 core structure.
Pang W; Wang RR; Gao YD; Yang LM; Sun Y; Huang JF; Tien P; Zheng YT
J Biomol Screen; 2011 Feb; 16(2):221-9. PubMed ID: 21297108
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the inhibition effect of arachidonic acid on the core structure of the HIV-1 gp41.
Xu X; Li L; Liu Z; Yao X; Zhang X; Liu S; Liu L
J Pharm Biomed Anal; 2018 Nov; 161():377-382. PubMed ID: 30199809
[TBL] [Abstract][Full Text] [Related]
18. HIV-1 gp41 fusion intermediate: a target for HIV therapeutics.
Pan C; Liu S; Jiang S
J Formos Med Assoc; 2010 Feb; 109(2):94-105. PubMed ID: 20206833
[TBL] [Abstract][Full Text] [Related]
19. The stability of the intact envelope glycoproteins is a major determinant of sensitivity of HIV/SIV to peptidic fusion inhibitors.
Gallo SA; Sackett K; Rawat SS; Shai Y; Blumenthal R
J Mol Biol; 2004 Jun; 340(1):9-14. PubMed ID: 15184018
[TBL] [Abstract][Full Text] [Related]
20. A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.
Cai L; Gochin M
Antimicrob Agents Chemother; 2007 Jul; 51(7):2388-95. PubMed ID: 17452484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
